Loading...
Prediction of Sustained Virological Response to Peginterferon-based Therapy for Chronic Hepatitis C: Regression Analysis of a Cohort from Rio Grande do Sul, Brazil
AIM: Peginterferon plus ribavirin (peg-IFN/RBV) is still the standard of care for treatment of hepatitis C virus (HCV) in many countries. Given the high toxicity of this regimen, our study aimed to develop a prediction tool that can identify which patients are unlikely to benefit from peg-IFN/RBV an...
Na minha lista:
| Udgivet i: | Euroasian J Hepatogastroenterol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Jaypee Brothers Medical Publishers
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5663770/ https://ncbi.nlm.nih.gov/pubmed/29201768 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5005/jp-journals-10018-1207 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|